New CAR-T treat­ments for can­cer will need to prove that they’re bet­ter than ex­ist­ing ther­a­pies to win FDA ap­proval, the agency’s bi­o­log­ics chief Vinay Prasad …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas
© Endpoints News 2025

source